Christopher Kim - May 16, 2025 Form 4 Insider Report for Apimeds Pharmaceuticals US, Inc. (APUS)

Role
Chairman and CMO, Director
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
Stock symbol
APUS
Transactions as of
May 16, 2025
Transactions value $
$0
Form type
4
Date filed
5/20/2025, 05:00 PM
Previous filing
May 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kim Christopher Chairman and CMO, Director C/O APIMEDS PHARMACEUTICALS US, INC., 2 EAST BROAD STREET, 2ND FLOOR, HOPEWELL /s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact 2025-05-20 0002040022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APUS Common Stock, par value $0.01 per share Award $0 +250K +909.09% $0.00 278K May 16, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.